Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baijun Fang

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Pediatric Transplantation|August 5, 2008
Cotransplantation of haploidentical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemiaBaijun Fang, Ning Li, Yongping Song, et al.
Bone Marrow Transplantation|September 21, 2019
Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA-CAR-T therapy in patient with relapsed myelomaQuande Lin, Xiyang Liu, Lu Han, et al.
International Journal of Hematology|November 23, 2013
Reduced intensity conditioning and co-transplantation of unrelated peripheral stem cells combined with umbilical cord mesenchymal stem/stroma cells for young patients with refractory severe aplastic anemiaYuewen Fu, Qian Wang, Jian Zhou, et al.
Biochemical and Biophysical Research Communications|March 6, 2021
Cereblon modulator CC-885 induces CRBN-dependent ubiquitination and degradation of CDK4 in multiple myelomaMin Zhao, Min Hu, Yong Chen, et al.
American Journal of Cancer Research|May 11, 2023
Low-dose decitabine plus bortezomib-dexamethasone therapy is well-tolerated and highly effective on first-relapsed multiple myeloma: a single-center phase 2 trialLijie Liang, Min Zhao, Yuzhang Liu, et al.
Pediatric Transplantation|October 4, 2007
Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two childrenBaijun Fang, Yongping Song, Quande Lin, et al.
Acta Haematologica|June 5, 2019
The Biological Function and Clinical Significance of miR-886-5p in Multiple MyelomaPu Xiang, Yuzhang Liu, Lina Liu, et al.
Experimental Hematology & Oncology|April 14, 2020
Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trialBinglei Zhang, Jian Zhou, Fengkuan Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 21, 2016
[Treatment of relapsed and refractory acute lymphocytic leukemia by modified CAG regimen]Hao Huang, Li'na Liu, Yuzhang Liu, et al.
Blood|December 14, 2004
Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristicsBaijun Fang, Chunmei Zheng, Lianming Liao, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Pediatric Transplantation|August 5, 2008
Cotransplantation of haploidentical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemiaBaijun Fang, Ning Li, Yongping Song, et al.
Bone Marrow Transplantation|September 21, 2019
Autologous hematopoietic stem cell infusion for sustained myelosuppression after BCMA-CAR-T therapy in patient with relapsed myelomaQuande Lin, Xiyang Liu, Lu Han, et al.
International Journal of Hematology|November 23, 2013
Reduced intensity conditioning and co-transplantation of unrelated peripheral stem cells combined with umbilical cord mesenchymal stem/stroma cells for young patients with refractory severe aplastic anemiaYuewen Fu, Qian Wang, Jian Zhou, et al.
Biochemical and Biophysical Research Communications|March 6, 2021
Cereblon modulator CC-885 induces CRBN-dependent ubiquitination and degradation of CDK4 in multiple myelomaMin Zhao, Min Hu, Yong Chen, et al.
American Journal of Cancer Research|May 11, 2023
Low-dose decitabine plus bortezomib-dexamethasone therapy is well-tolerated and highly effective on first-relapsed multiple myeloma: a single-center phase 2 trialLijie Liang, Min Zhao, Yuzhang Liu, et al.
Pediatric Transplantation|October 4, 2007
Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two childrenBaijun Fang, Yongping Song, Quande Lin, et al.
Acta Haematologica|June 5, 2019
The Biological Function and Clinical Significance of miR-886-5p in Multiple MyelomaPu Xiang, Yuzhang Liu, Lina Liu, et al.
Experimental Hematology & Oncology|April 14, 2020
Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trialBinglei Zhang, Jian Zhou, Fengkuan Yu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 21, 2016
[Treatment of relapsed and refractory acute lymphocytic leukemia by modified CAG regimen]Hao Huang, Li'na Liu, Yuzhang Liu, et al.
Blood|December 14, 2004
Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristicsBaijun Fang, Chunmei Zheng, Lianming Liao, et al.
Pageof 9